Parker Flex-it Stylet Versus Malleable Stylet in Orotracheal Intubation Using a Fiber-optic Laryngoscope
Parker Flex-it Directional Stylet Versus Conventional Malleable Stylet in Elective Orotracheal Intubation Using a Fiber-optic Laryngoscope
1 other identifier
interventional
80
1 country
1
Brief Summary
Objectives: To compare the safety and efficacy of Parker flex-it directional stylet (PFDS) versus conventional malleable stylet (CMS) in orotracheal intubation (OTI) using fiber-optic Macintosh laryngoscope. Background: OTI is used in general anesthesia for anesthetic delivery and ventilation of patients. OTI delay or failure may adversely affect patient outcomes, therefore, anesthetists with sufficient clinical experience and skill should perform OTI. However, in emergency situations, experienced anesthetists may not be available, and the patient may have a high Cormack-Lehane grade. A stylet is commonly used in the emergency department to aid insertion of the endotracheal tube during direct laryngoscopy. Patients and Methods: This was a prospective, randomized, double-blind clinical trial; carried out on 80 patients requiring OTI under general anesthesia at our hospital. Patients were randomly allocated into two equal groups; group DS, intubated using PFDS, and group MS, intubated using CMS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 21, 2021
CompletedFirst Posted
Study publicly available on registry
April 23, 2021
CompletedStudy Start
First participant enrolled
May 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2022
CompletedApril 22, 2022
April 1, 2021
11 months
April 21, 2021
April 15, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mean and Standard deviation of Time required for orotracheal intubation (seconds) (mean±SD)
Time interval from holding the endotracheal tube by the anesthetist till removal of the stylet from the endotracheal tube by the anesthetist
2 minutes after inserting the blade of the laryngoscope in the mouth
Secondary Outcomes (8)
Mean and Standard deviation of Total time required for orotracheal intubation (seconds) (mean±SD)
2 minutes after inserting the blade of the laryngoscope in the mouth
Mean and Standard deviation of Number of intubation attempts (mean±SD)
2 minutes after inserting the blade of the laryngoscope in the mouth
Number of participants and Rate of Successful intubation from the first-attempt
2 minutes after inserting the blade of the laryngoscope in the mouth
Number of participants and Rate of Use of external laryngeal manipulation
2 minutes after inserting the blade of the laryngoscope in the mouth
Mean and Standard deviation of Heart rate (beat/min.)(mean±SD)
2 minutes after inserting the blade of the laryngoscope in the mouth
- +3 more secondary outcomes
Study Arms (2)
Group DS (n=40)
ACTIVE COMPARATORParker Flex-it Directional Stylet group
Group MS (n=40)
ACTIVE COMPARATORConventional Malleable Stylet group
Interventions
Eligibility Criteria
You may qualify if:
- American Society of Anesthesiologists (ASA) physical status ≤ II
- Age from 21 to 60 years
- Body Mass Index (BMI) \< 35
- Mallampati classification ≤ II
You may not qualify if:
- American Society of Anesthesiologists (ASA) physical status \> II
- Age \< 21 years or \> 60 years
- Body Mass Index (BMI) ≥ 35
- Mallampati classification \> II
- Pregnant women
- Anticipated difficult airway
- Need for rapid sequence induction
- Increased risk of gastric aspiration such as gastroesophageal reflux
- Edentulous patients, Loose teeth
- Known pathology, trauma, or previous surgery to the mouth, pharynx, larynx, or cervical spine
- History of; Dysrhythmia, Hypertension, Ischemic heart disease, Hyperthyroidism, DM
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Damanhour Teaching Hospital
Damanhūr, El-Beheira, Egypt
Study Officials
- PRINCIPAL INVESTIGATOR
Ahmed M Shaat, MD
Damanhour Teaching Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 21, 2021
First Posted
April 23, 2021
Study Start
May 1, 2021
Primary Completion
March 15, 2022
Study Completion
March 15, 2022
Last Updated
April 22, 2022
Record last verified: 2021-04